APA (7th ed.) Citation

LT, M., VE, F., EF, D. C., GJ, L., L, C., AM, C., . . . CS, P. L. (2026). Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of GSTP1 c.313A>G genotyping. PloS one, 21(4), e0345371. https://doi.org/10.1371/journal.pone.0345371

Chicago Style (17th ed.) Citation

LT, Macedo, Ferrari VE, Dias Costa EF, Lourenço GJ, Calonga L, Castilho AM, Chone CT, and Passos Lima CS. "Pharmacogenetic Strategies to Mitigate Cisplatin-induced Ototoxicity in Head and Neck Cancer: A Cost-minimization Analysis with the Use of GSTP1 C.313A>G Genotyping." PloS One 21, no. 4 (2026): e0345371. https://doi.org/10.1371/journal.pone.0345371.

MLA (9th ed.) Citation

LT, Macedo, et al. "Pharmacogenetic Strategies to Mitigate Cisplatin-induced Ototoxicity in Head and Neck Cancer: A Cost-minimization Analysis with the Use of GSTP1 C.313A>G Genotyping." PloS One, vol. 21, no. 4, 2026, p. e0345371, https://doi.org/10.1371/journal.pone.0345371.